Multifaceted Roles of UFMylation in Health and Disease

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2025 Jan 8

PMID 39775503

Authors

Ru-Na Wang

Lin Li

Jun Zhou

Jie Ran

Affiliations

Soon will be listed here.

Abstract

Ubiquitin fold modifier 1 (UFM1) is a newly identified post-translational modifier that is involved in the UFMylation process. Similar to ubiquitination, UFMylation enables the conjugation of UFM1 to specific target proteins, thus altering their stability, activity, or localization. UFM1 chains have the potential to undergo cleavage from their associated proteins via UFM1-specific proteases, thus highlighting a reversible feature of UFMylation. This modification is conserved across nearly all eukaryotic organisms, and is associated with diverse biological activities such as hematopoiesis and the endoplasmic reticulum stress response. The disruption of UFMylation results in embryonic lethality in mice and is associated with various human diseases, thus underscoring its essential role in embryonic development, tissue morphogenesis, and organismal homeostasis. In this review, we aim to provide an in-depth overview of the UFMylation system, its importance in disease processes, and its potential as a novel target for therapeutic intervention.

References

Lee J, Hammaren H, Savitski M, Baek S . Control of protein stability by post-translational modifications. Nat Commun. 2023; 14(1):201. PMC: 9839724. DOI: 10.1038/s41467-023-35795-8. View

Cappadocia L, Lima C . Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism. Chem Rev. 2017; 118(3):889-918. PMC: 5815371. DOI: 10.1021/acs.chemrev.6b00737. View

Wang X, Lv X, Ma J, Xu G . UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions. Pharmacol Ther. 2024; 260:108680. DOI: 10.1016/j.pharmthera.2024.108680. View

Ha B, Ahn H, Kang S, Tanaka K, Chung C, Kim E . Structural basis for Ufm1 processing by UfSP1. J Biol Chem. 2008; 283(21):14893-900. DOI: 10.1074/jbc.M708756200. View

Millrine D, Cummings T, Matthews S, Peter J, Magnussen H, Lange S . Human UFSP1 is an active protease that regulates UFM1 maturation and UFMylation. Cell Rep. 2022; 40(5):111168. PMC: 9638016. DOI: 10.1016/j.celrep.2022.111168. View

Zhou X, Mahdizadeh S, Le Gallo M, Eriksson L, Chevet E, Lafont E . UFMylation: a ubiquitin-like modification. Trends Biochem Sci. 2023; 49(1):52-67. DOI: 10.1016/j.tibs.2023.10.004. View

Komatsu M, Inada T, Noda N . The UFM1 system: Working principles, cellular functions, and pathophysiology. Mol Cell. 2023; 84(1):156-169. DOI: 10.1016/j.molcel.2023.11.034. View

Peter J, Magnussen H, DaRosa P, Millrine D, Matthews S, Lamoliatte F . A non-canonical scaffold-type E3 ligase complex mediates protein UFMylation. EMBO J. 2022; 41(21):e111015. PMC: 9627666. DOI: 10.15252/embj.2022111015. View

Yoo H, Kang S, Kim J, Lee J, Seong M, Lee S . Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. Mol Cell. 2014; 56(2):261-274. DOI: 10.1016/j.molcel.2014.08.007. View

10.

Komatsu M, Chiba T, Tatsumi K, Iemura S, Tanida I, Okazaki N . A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 2004; 23(9):1977-86. PMC: 404325. DOI: 10.1038/sj.emboj.7600205. View

11.

Soudah N, Padala P, Hassouna F, Kumar M, Mashahreh B, Lebedev A . An N-Terminal Extension to UBA5 Adenylation Domain Boosts UFM1 Activation: Isoform-Specific Differences in Ubiquitin-like Protein Activation. J Mol Biol. 2018; 431(3):463-478. DOI: 10.1016/j.jmb.2018.10.007. View

12.

Kang S, Kim G, Seong M, Baek S, Seol J, Bang O . Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J Biol Chem. 2006; 282(8):5256-62. DOI: 10.1074/jbc.M610590200. View

13.

Sasakawa H, Sakata E, Yamaguchi Y, Komatsu M, Tatsumi K, Kominami E . Solution structure and dynamics of Ufm1, a ubiquitin-fold modifier 1. Biochem Biophys Res Commun. 2006; 343(1):21-6. DOI: 10.1016/j.bbrc.2006.02.107. View

14.

Liang Q, Jin Y, Xu S, Zhou J, Mao J, Ma X . Human UFSP1 translated from an upstream near-cognate initiation codon functions as an active UFM1-specific protease. J Biol Chem. 2022; 298(6):102016. PMC: 9168615. DOI: 10.1016/j.jbc.2022.102016. View

15.

Ha B, Jeon Y, Shin S, Tatsumi K, Komatsu M, Tanaka K . Structure of ubiquitin-fold modifier 1-specific protease UfSP2. J Biol Chem. 2011; 286(12):10248-57. PMC: 3060479. DOI: 10.1074/jbc.M110.172171. View

16.

Gavin J, Hoar K, Xu Q, Ma J, Lin Y, Chen J . Mechanistic study of Uba5 enzyme and the Ufm1 conjugation pathway. J Biol Chem. 2014; 289(33):22648-22658. PMC: 4132772. DOI: 10.1074/jbc.M114.573972. View

17.

Habisov S, Huber J, Ichimura Y, Akutsu M, Rogova N, Loehr F . Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation. J Biol Chem. 2016; 291(17):9025-41. PMC: 4861472. DOI: 10.1074/jbc.M116.715474. View

18.

Oweis W, Padala P, Hassouna F, Cohen-Kfir E, Gibbs D, Todd E . Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex. Cell Rep. 2016; 16(12):3113-3120. DOI: 10.1016/j.celrep.2016.08.067. View

19.

Kumar M, Padala P, Fahoum J, Hassouna F, Tsaban T, Zoltsman G . Structural basis for UFM1 transfer from UBA5 to UFC1. Nat Commun. 2021; 12(1):5708. PMC: 8481289. DOI: 10.1038/s41467-021-25994-6. View

20.

Gerakis Y, Quintero M, Li H, Hetz C . The UFMylation System in Proteostasis and Beyond. Trends Cell Biol. 2019; 29(12):974-986. PMC: 6917045. DOI: 10.1016/j.tcb.2019.09.005. View